CANTO-Cog results presented at ESMO

The platform was present at the ESMO (European Society for Medical Oncology) virtual congress in September 2021. The results on the cognitive follow-up of patients treated for breast cancer of the national cohort ANR-CANTO were presented (poster).

Cognitive impairment in breast cancer patients up to 18 months after cancer treatments: the French multicentric longitudinal CANTO-Cog cohort substudy.